Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CNTB - Connect Biopharma: A Last Hurrah From CBP-307

CNTB - Connect Biopharma: A Last Hurrah From CBP-307

Connect Biopharma Holdings Limited

Summary

  • The Ulcerative Colitis trial is the sole clinical catalyst in H1 2023.
  • It will likely succeed, although the drug candidate has no future without a partner.
  • Plan B is still the lead drug CBP-201 in China's atopic dermatitis market.

For further details see:

Connect Biopharma: A Last Hurrah From CBP-307
Stock Information
Company Name: Connect Biopharma Holdings Limited
Stock Symbol: CNTB
Market: NASDAQ
Website: connectbiopharm.com
Menu
CNTB CNTB Quote CNTB Short CNTB News CNTB Articles CNTB Message Board
Get CNTB Alerts

News, Short Squeeze, Breakout and More Instantly...